Wargacki Stephen 4
4 · Aquestive Therapeutics, Inc. · Filed Mar 11, 2025
Insider Transaction Report
Form 4
Wargacki Stephen
Chief Science Officer
Transactions
- Award
Common Stock
2025-03-07+115,000→ 376,414 total - Tax Payment
Common Stock
2025-03-07$2.65/sh−12,859$34,076→ 363,555 total - Tax Payment
Common Stock
2025-03-10$2.54/sh−4,572$11,613→ 343,552 total - Award
Non-Qualified Stock Option (right to buy)
2025-03-07+65,000→ 65,000 totalExercise: $2.65Exp: 2035-03-07→ Common Stock (65,000 underlying) - Tax Payment
Common Stock
2025-03-09$2.65/sh−15,431$40,892→ 348,124 total
Footnotes (3)
- [F1]The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
- [F2]Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.
- [F3]The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.